[1] [1] O. M. Muhling, Y. Wang, P. Panse et al.. Transmyocardial laser revascularization preserves regional myocardial perfusion: an MRI first pass perfusion study [J]. Cardiovasc. Res., 2003, 57(1):63～70

[2] [2] S. Paul, M. Nathan, J. G. Byrne et al.. Transmyocardial laser revascularization [J]. Cardiothorac Vasc. Anesth, 2004, 18(1):85～92

[3] [3] C. Liu, Z. Sun, X. Du et al.. Implantation of endothelial progenitor cells into laser-induced channels in rat ischemia hindlimb augments neovascularization [J]. Ann. Vasc. Surg., 2005, 19(2):241～247

[4] [4] P. M. Schofield, L. D. Sharples, N. Caine et al.. Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial [J]. Lancet, 1999, 353(9152):519～524

[5] [5] E. D. Jansen, M. Frenz, K. A. Kadipasoaglu et al.. Laser-tissue interaction during transmyocardial laser revascularization [J]. Ann. Thorac. Surg., 1997, 63(3):640～647

[6] [6] O. H. Frazier, R. J. March, K. A. Horvath et al.. Transmyocardial revascularization with a carcon dioxide laser in patients with end-stage coronary artery disease [J]. N. Engl. J. Med., 1999, 341(14):1021～1028

[7] [7] N. Yamamoto, T. Kohmoto, A. Gu et al.. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization [J]. J. Am. Coll. Cardiol., 1998, 31(6):1426～1433

[8] [8] G. Lutter, K. Sarai, E. Nitzsche et al.. Evaluation of transmyocardial laser revascularization by following objective parameters of perfusion and ventricular function [J]. Thorac. Cardiovasc. Surg., 2000, 48(2):79～85

[9] [9] Huang Ping, Liu Chengyi, Xu Xiaoyang et al.. Photobiomodulation action of the marginal irradiation of high intensity KTP laser irradiations on monolayer skin fibroblasts [J]. Chinese J. Lasers, 2005, 32(5):723～728

[10] [10] E. Ibrahim, J. Ligntner, D. G. Pennington et al.. Cellular cardiomyoplasty and transmyocardial laser revascularization for chronic ischemic heart [J]. FASEB J., 2006, 20(3):A315

[11] [11] H. M. Klein, A. Ghodsizad, A. Borowski et al.. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases [J]. Heart. Surg. Forum., 2004, 7(5):E416～419

[12] [12] Liu Chao, Xu Jing, Luo Hong et al.. Study on injectable endothelial progenitor cells-carrier composite [J]. Chinese Journal of Biomedical Engineering, 2007, 17(2):151～155

[13] [13] A. Kawamoto, D. W. Losordo. Endothelial progenitor cells for cardiovascular regeneration [J]. Trends Cardiovasc. Med., 2008, 18(1):33～37